Slide 1Slide 2Slide 3Slide 4Slide 5Slide 6Slide 7Slide 8Slide 9Slide 10Slide 11Slide 12Slide 13Slide 14Slide 15Slide 16Slide 17Slide 18Characterization of Phthalate Exposure among Pregnant Women Assessed by Repeat Air and Urine SamplesXIAOZHUO LUOutline•Background•Method–Study population–Phthalate measures–Urinary metabolite measures–Personal and indoor air analysis–Statistical analysis•Result–Background characteristics of the study sample–Urinary phthalate metabolites in pregnant women and newborns–Phthalate measurements in personal and indoor air–Variability study: urinary phthalate metabolites.–Variability study: phthalate measures in air.–Association between phthalate levels measured in air and urine.•Discussion•ConclusionBackground•Phthalates are a class of synthetic compounds used widely in polyvinyl chloride plastics, in cosmetics, and in building materials.•The primary aim of the current study was to use biomarkers of exposure to evaluate variability in phthalate concentrations in pregnant women; and to evaluate variability in measures of phthalates in their external environment. •As a secondary aim, the research evaluated correlations between phthalate metabolite concentrations measured in maternal and newborn urine. •Finally, the research evaluated the correlation between phthalate levels in personal/indoor air and urinary metabolite concentrations.Method•Study population-To be eligible for enrollment, subjects had to reside in the study area for at least 1 year, receive their first prenatal visit by the 20th week of pregnancy, and be free of diabetes, hypertension, and known HIV and drug or alcohol abuse.-At the time of enrollment, all subjects completed a prenatal questionnaire.-Information was also abstracted from prenatal and delivery medical records.Method•Phthalate measures–The variability study was carried out on a subset of subjects (n = 32) who completed the 48-hr personal monitoring.–Indoor air monitors placed in the women’s apartments ran continuously for 2 weeks.Method•Urinary metabolite measures The analytical approach for measuring urinary phthalate metabolites involved enzymatic deconjugation of the metabolites from their glucuronidated form, solid-phase extraction, separation with high-performance liquid chromatography, and detection by isotope-dilution tandem mass spectrometry (Blount et al.Method•Personal and indoor air analysis After being stored and shipped at –4°C, the PUF and filter were soxhlet-extracted with 6% diethyl ether in hexane and concentrated to 10 mL, of which an aliquot was used for phthalate analysis.Method•Statistical analysis -They used publicly accessible urinary concentration data from NHANES 1999–2000 and 2001–2002 for eight metabolites to estimate the mean concentrations in U.S. females between the ages of 18 and 40 years. -Additionally, they calculated the geometric mean concentration and 95% CI for U.S. pregnant females.Result•Background characteristics of the study sample.–The subjects in the variability study were similar in age and marital status and were more likely to have a lower educational level.Result•Urinary phthalate metabolites in pregnant women and newborns.–We found no correlation between phthalate metabolite concentrations measured in urine samples collected from mothers and their newborns approximately 1 day after delivery.–For three metabolites, there was a suggestive inverse correlation between the geometric mean of 19 mothers’ samples with their newborns’ urinary metabolites measured 1 day after delivery.Result•Phthalate measurements in personal and indoor air–When they limited the analysis to subjects who had both a personal air and indoor air sample (n = 27), there was a positive correlation between 48-hr personal air and the average indoor air levels over the 8 weeks of sampling for all five phthalate diesters, estimated as 0.54 for DnBP (p = 0.002), 0.67 for BBzP (p < 0.0001), 0.51 for DEP (p = 0.005), 0.31 for DiBP (p = 0.11), and 0.25 for DEHP (p = 0.21) (Figure 2).Result•Variability study: urinary phthalate metabolites.–We evaluated the sensitivity and specificity of characterizing exposure based on a single sample compared with all available samples using women who had three to five repeated urine samples over 8 weeks.Result•Variability study: phthalate measures in air–Within a woman’s home, the indoor air phthalate levels were more stable over time than were her urinary phthalates.Result•Association between phthalate levels measured in air and urine.–No associations were detected between DEHP or DnBP and their respective metabolites.Discussion•Within-subject variability in phthalate concentrations measured in indoor air during the same 6-week period was lower than that in urine, suggesting that exposures to phthalates are relatively constant within the home.•Poor reproducibility for DEHP might mean the air concentrations are dependent on dust concentrations at the time of sampling, which could be associated with intermittent activities such as cleaning and moving furniture. BBzP was the most stable phthalate measured in indoor air.Conclusion•In the present study, we found urinary phthalate metabolite concentrations to be moderately to highly variable in a small sample of pregnant women sampled over 6 weeks late in pregnancy, whereas indoor air concentrations were more stable during the same period.•The findings also suggest that creatinine adjustment might not be the optimal method of urinary dilution adjustment for subjects sampled late in pregnancy.Further research•Future research should be directed at increasing the number of urine samples collected and the number of intervals between samples over the duration of the pregnancy to reduce misclassification in measures of phthalate exposure.Thank